Catalent (NYSE:CTLT) rose 2% amid a report that the European Union's antitrust regulator will likely grant approval for its planned sale
https://seekingalpha.com/news/4322149-catalent-gains-on-report-its-likely-to-be-granted-eu-approval-for-novo-holdings-deal
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.